Literature DB >> 17828747

Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.

Silvia Einaudi1, Nicoletta Bertorello, Nicoletta Masera, Loredana Farinasso, Elena Barisone, Carmelo Rizzari, Andrea Corrias, Alessia Villa, Francesca Riva, Paola Saracco, Guido Pastore.   

Abstract

BACKGROUND: A 4-week course of high-dose glucocorticoids may cause prolonged adrenal suppression even after a 9-day tapering phase. In this study, adrenal function and signs and symptoms of adrenal insufficiency were prospectively assessed in children with acute lymphoblastic leukemia (ALL) after induction treatment including high-dose prednisone (PDN) or dexamethasone (DXM). PROCEDURES: Sixty-four children with ALL, treated according to the AIEOP ALL 2000 Study protocol, underwent low dose ACTH (LD-ACTH) stimulation 24 hr after the last tapered steroid dose. In those with impaired cortisol response, additional LD ACTH tests were performed every 1-2 weeks until cortisol levels normalized. Signs and symptoms of adrenal insufficiency were recorded during the observation period.
RESULTS: All patients had normal basal cortisol values at diagnosis. Twenty-four hours after last glucocorticoid dose, morning cortisol was reduced in 40/64 (62.5%) patients. LD-ACTH testing showed adrenal suppression in 52/64 (81.5%) patients. At the following ACTH test 7-14 days later, morning cortisol values were reduced in 8/52 (15.4%) patients and response to the test was impaired in 12/52 (23%). Adrenal function completely recovered in all patients within 10 weeks. No difference was found between patients treated with PDN or DXM. Almost 35% of children with impaired cortisol values at the first test developed signs or symptoms of adrenal insufficiency. One child developed a severe adrenal crisis during adrenal suppression.
CONCLUSIONS: High-dose glucocorticoid therapy in ALL children may cause prolonged adrenal suppression and related clinical symptoms. Laboratory monitoring of cortisol levels and steroid coverage during stress episodes may be indicated. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17828747     DOI: 10.1002/pbc.21339

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  19 in total

Review 1.  Recovery of steroid induced adrenal insufficiency.

Authors:  Areej K Younes; Noor K Younes
Journal:  Transl Pediatr       Date:  2017-10

2.  Adrenal suppression: An under-recognized complication of a common therapy.

Authors:  Ellen Goldbloom; Alexandra Ahmet
Journal:  Paediatr Child Health       Date:  2010-09       Impact factor: 2.253

3.  Survival among children diagnosed with acute lymphoblastic leukemia in the United States, by race and age, 2001 to 2009: Findings from the CONCORD-2 study.

Authors:  Eric W Tai; Kevin C Ward; Audrey Bonaventure; David A Siegel; Michel P Coleman
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

4.  Recovery of the hypothalamic-pituitary-adrenal axis in children and adolescents after surgical cure of Cushing's disease.

Authors:  Maya Lodish; Somya Verma Dunn; Ninet Sinaii; Margaret F Keil; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2012-03-07       Impact factor: 5.958

5.  Prospective evaluation of local control and late effects of conformal radiation therapy in children, adolescents, and young adults with high-grade glioma.

Authors:  Tamara Z Vern-Gross; Jane E Schreiber; Alberto Broniscer; Shengjie Wu; Xiaoping Xiong; Thomas E Merchant
Journal:  Neuro Oncol       Date:  2014-06-07       Impact factor: 12.300

Review 6.  Late effects of childhood leukemia therapy.

Authors:  Joy M Fulbright; Sripriya Raman; Wendy S McClellan; Keith J August
Journal:  Curr Hematol Malig Rep       Date:  2011-09       Impact factor: 3.952

Review 7.  Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.

Authors:  Niki Rensen; Reinoud Jbj Gemke; Elvira C van Dalen; Joost Rotteveel; Gertjan Jl Kaspers
Journal:  Cochrane Database Syst Rev       Date:  2017-11-06

8.  Corticosteroid physiology and principles of therapy.

Authors:  Priyanka Gupta; Vijayalakshmi Bhatia
Journal:  Indian J Pediatr       Date:  2008-11-21       Impact factor: 1.967

9.  Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy.

Authors:  Alexandra Ahmet; Harold Kim; Sheldon Spier
Journal:  Allergy Asthma Clin Immunol       Date:  2011-08-25       Impact factor: 3.406

10.  Screening practices for paediatric asymptomatic adrenal suppression in Canada: Are we addressing this important risk?

Authors:  Ellen B Goldbloom; Alexandra Ahmet
Journal:  Paediatr Child Health       Date:  2019-03-30       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.